Weight-Loss Drugs Could Cost Just $3 a Month to Make as Patents End

Weight-Loss Drugs Could Cost Just $3 a Month to Make as Patents End

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low and middle-income countries.

Anti-obesity treatment could cost as little as $3 per month: study

Read: 2 min A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low and middle-income countries. Semaglutide, the active molecule in Novo Nordisk’s Ozempic and Wegovy treatments, leads to considerable weight-loss in patients and thus can provide major help in managing diabetes and other …

Anti-Obesity Drug Could Cost Just $3 Per Month, Study Finds

What if one of the world’s most talked-about weight-loss drugs suddenly became affordable for almost everyone? That possibility may be closer than many think.Researchers say semaglutide—the active ingredient behind blockbuster treatments like Ozempic and Wegovy made by Novo Nordisk—could cost as little as $3 per month to manufacture.Once patents expire in several countries later this month.Right now, the branded versions can cost about $200 a mo…

Generic Ozempic could cost less than $3 a month, study shows

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study shows, underscoring their potential to unlock global access to powerful weight-loss drugs.